ATR

MKT CAP:$8B

AptarGroup, Inc.

Market Cap

$8B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$130.63+$8.09 (+6.60%)

Apr 17, 2026

Company Details

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company ope...

CEO

Stephan Tanda

IPO Date

Apr 23, 1993

Website

www.aptar.com

Key Metrics TTM

Revenue

$3.8B

+5.4% YoY

Net Income

$393M

EPS (Diluted)

$5.89

Free Cash Flow

$296M

Revenue / Share

$57.41

Gross Margin

29.6%

Operating Margin

13.5%

Net Margin

10.4%

FCF Margin

7.8%

P/S

2.1x

P/E

20.3x

Earnings Reports

Q1 2026

Apr 30, 2026

PENDING

FY 2025

Feb 6, 2026

$3.8B+5.4%EPS $5.89

Q4 2025

Feb 6, 2026

$963M+13.5%EPS $1.13

Q3 2025

Oct 31, 2025

$961M+5.7%EPS $1.92

Q2 2025

Aug 1, 2025

$966M+6.1%EPS $1.67

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$814M	$292M	$87M
Q1 22	$845M	$302M	$98M
Q2 22	$845M	$296M	$101M
Q3 22	$837M	$290M	$95M
Q1 23	$860M	$303M	$84M
Q2 23	$896M	$322M	$117M
Q3 23	$893M	$326M	$119M
Q4 23	$838M	$312M	$84M
Q1 24	$915M	$333M	$112M
Q2 24	$910M	$343M	$126M
Q3 24	$909M	$351M	$138M
Q4 24	$848M	$329M	$120M
Q1 25	$887M	$336M	$113M
Q2 25	$966M	$297M	$146M
Q3 25	$961M	$288M	$139M
Q4 25	$963M	$196M	$112M

Valuation

Quarter	P/S	P/E
Q4 21	2.5x	31.8x
Q1 22	2.5x	30.7x
Q2 22	2.4x	33.3x
Q3 22	2.4x	33.4x
Q1 23	2.3x	33.8x
Q2 23	2.3x	31.1x
Q3 23	2.3x	28.8x
Q4 23	2.3x	28.0x
Q1 24	2.2x	25.4x
Q2 24	2.2x	24.8x
Q3 24	2.2x	23.7x
Q4 24	2.2x	21.2x
Q1 25	2.2x	21.5x
Q2 25	2.2x	20.3x
Q3 25	2.2x	19.0x
Q4 25	2.1x	20.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$104M	$13M
Q1 22	$92M	$19M
Q2 22	$85M	$10M
Q3 22	$130M	$46M
Q1 23	$98M	$20M
Q2 23	$84M	$6M
Q3 23	$173M	$95M
Q4 23	$220M	$136M
Q1 24	$92M	$17M
Q2 24	$144M	$75M
Q3 24	$229M	$149M
Q4 24	$178M	$108M
Q1 25	$83M	$23M
Q2 25	$126M	$61M
Q3 25	$178M	$114M
Q4 25	$184M	$97M

Capital Expenditures

Quarter	CapEx
Q4 21	$91M
Q1 22	$73M
Q2 22	$74M
Q3 22	$84M
Q1 23	$78M
Q2 23	$78M
Q3 23	$79M
Q4 23	$84M
Q1 24	$76M
Q2 24	$68M
Q3 24	$80M
Q4 24	$71M
Q1 25	$59M
Q2 25	$65M
Q3 25	$63M
Q4 25	$87M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+7.2%	+10.1%
Q1 22	+12.8%	+11.9%
Q2 22	+8.7%	+8.7%
Q3 22	+3.2%	+2.1%
Q1 23	+5.7%	+6.8%
Q2 23	+6.0%	+4.3%
Q3 23	+5.7%	+4.1%
Q4 23	+0.2%	+1.7%
Q1 24	+6.4%	+3.5%
Q2 24	+1.6%	+0.6%
Q3 24	+1.8%	-0.3%
Q4 24	+1.1%	-3.5%
Q1 25	-3.1%	-3.7%
Q2 25	+6.1%	+4.6%
Q3 25	+5.7%	+6.6%
Q4 25	+13.5%	+16.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$9M	1.1%
Q1 22	$13M	1.6%
Q2 22	$9M	1.0%
Q3 22	$10M	1.2%
Q1 23	$15M	1.7%
Q2 23	$10M	1.2%
Q3 23	$11M	1.2%
Q4 23	$5M	0.6%
Q1 24	$18M	2.0%
Q2 24	$9M	1.0%
Q3 24	$10M	1.1%
Q4 24	$10M	1.1%
Q1 25	$19M	2.2%
Q2 25	$8M	0.8%
Q3 25	$17M	1.8%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 21	$277M	$411M
Q1 22	—	$146M
Q2 22	—	$135M
Q3 22	—	$135M
Q1 23	—	$148M
Q2 23	—	$141M
Q3 23	—	$138M
Q4 23	$93M	$138M
Q1 24	—	$153M
Q2 24	—	$149M
Q3 24	—	$142M
Q4 24	—	$139M
Q1 25	—	$155M
Q2 25	—	$151M
Q3 25	$455M	$306M
Q4 25	$151M	—

Revenue Segments

Quarter	Beauty And Home	Food + Beverage	Pharma
Q4 21	$375M	$132M	$346M
Q1 22	$368M	$134M	$342M
Q2 22	$371M	$133M	$340M
Q3 22	$360M	$134M	$343M

Revenue by Geography

Quarter	Asia	Europe	Latin America	North America
Q1 23	$53M	$496M	$63M	$248M
Q2 23	$55M	$525M	$71M	$245M
Q3 23	$56M	$509M	$73M	$255M
Q1 24	$91M	$474M	$72M	$278M
Q2 24	$92M	$450M	$78M	$290M
Q3 24	$103M	$445M	$69M	$292M
Q1 25	$94M	$439M	$73M	$282M
Q2 25	$104M	$476M	$76M	$310M
Q3 25	$120M	$466M	$75M	$300M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$356M	$717.0K	$356M
Q2 22	$240M	$0	$240M
Q3 22	$125M	$0	$125M
Q4 22	$142M	$0	$142M
Q1 23	$127M	$0	$127M
Q2 23	$121M	$21.0K	$121M
Q3 23	$152M	$0	$152M
Q4 23	$224M	$0	$224M
Q1 24	$200M	$1M	$201M
Q2 24	$221M	$2M	$224M
Q3 24	$326M	$2M	$328M
Q4 24	$224M	$2M	$226M
Q1 25	$126M	$11M	$137M
Q2 25	$162M	$8M	$170M
Q3 25	$257M	$8M	$265M
Q4 25	$402M	$7M	$410M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	67M	-1.0%	+0.8%
Q1 22	67M	-0.4%	-0.2%
Q2 22	67M	-0.4%	-1.1%
Q3 22	67M	-0.5%	-2.2%
Q1 23	67M	+0.2%	-1.0%
Q2 23	67M	+0.2%	-0.4%
Q3 23	67M	+0.3%	+0.2%
Q4 23	67M	+0.1%	+0.8%
Q1 24	67M	+0.4%	+1.0%
Q2 24	68M	+0.2%	+1.1%
Q3 24	68M	+0.2%	+1.0%
Q4 24	68M	+0.3%	+1.2%
Q1 25	67M	-0.6%	+0.1%
Q2 25	67M	-0.3%	-0.5%
Q3 25	67M	-0.3%	-1.0%
Q4 25	66M	-1.9%	-3.1%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	$62.6K	13K
Q1 22	$65.0K	13K
Q2 22	$65.0K	13K
Q3 22	$64.4K	13K
Q1 23	$63.7K	14K
Q2 23	$66.4K	14K
Q3 23	$66.1K	14K
Q4 23	$60.8K	14K
Q1 24	$66.3K	14K
Q2 24	$65.9K	14K
Q3 24	$65.9K	14K
Q4 24	$62.8K	14K
Q1 25	$65.7K	14K
Q2 25	$71.6K	14K
Q3 25	$71.2K	14K
Q4 25	$68.8K	14K

Revenue / Employee